MDM2 in breast cancer

被引：15
|
作者：
Masakazu Toi
Shigehira Saji
Akio Suzuki
Yutaka Yamamoto
Takeshi Tominaga
机构：
[1] Tokyo Metropolitan Komagome Hospital,Department of Surgery
来源：
Breast Cancer | 1997年 / 4卷 / 4期
关键词：
MDM2; Breast cancer; Drug resistance;
D O I：
10.1007/BF02966519
中图分类号：
学科分类号：
摘要：
TheMDM2 protein, an oncogene product, is known to act by suppressing p53 function. Although gene amplification ofMDM2 was frequently detected in human sarcomas, it was uncommon in the majority of epithelial tumors including breast cancer. However, recent reports have demonstrated that its translational activity is enhanced in a variety of carcinomas. In this report, we summarized the implications ofMDM2 overexpression in human breast cancer from the literature as well as our preliminary results.
引用
收藏
页码：264 / 268
页数：4
相关论文
共 50 条
  • [31] MDM2 amplification is rare in gastric cancer
    Abdullazade, Samir
    Behrens, Hans-Michael
    Krueger, Sandra
    Haag, Jochen
    Roecken, Christoph
    VIRCHOWS ARCHIV, 2023, 483 (06) : 795 - 807
  • [32] MDM2 amplification is rare in gastric cancer
    Samir Abdullazade
    Hans-Michael Behrens
    Sandra Krüger
    Jochen Haag
    Christoph Röcken
    Virchows Archiv, 2023, 483 : 795 - 807
  • [33] MDM2 Inhibitors for Pancreatic Cancer Therapy
    Azmi, A. S.
    Philip, P. A.
    Almhanna, K.
    Beck, F. W.
    Kafri, Z. K.
    Sarkar, F. H.
    Mohammad, R. M.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2010, 10 (06) : 518 - 526
  • [34] MDM2 silencing promotes tumor-initiating cells in osteosarcoma and breast cancer
    Olivos, David J.
    Mayo, Lindsey D.
    CANCER RESEARCH, 2015, 75
  • [35] MDM2 promotes p53-independent breast cancer metastatic phenotypes
    Gao, Chong
    Kundu, Nandini
    Bargonetti, Jill
    CANCER RESEARCH, 2015, 75
  • [36] MDM2 Molecular Imaging for the Prediction of Chemotherapeutic Sensitivity in Human Breast Cancer Xenograft
    Fu, Peng
    Sun, Li
    Cao, Xueliang
    Li, Li
    Zhao, Changjiu
    MOLECULAR IMAGING, 2014, 13
  • [37] Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer
    Lukas, J
    Gao, DQ
    Keshmeshian, M
    Wen, WH
    Tsao-Wei, D
    Rosenberg, S
    Press, MF
    CANCER RESEARCH, 2001, 61 (07) : 3212 - 3219
  • [38] Mdm2 sensitizes MCF7 breast cancer cells to cisplatin or carboplatin
    Martin L. Smith
    Breast Cancer Research and Treatment, 1999, 58 : 99 - 105
  • [39] Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
    Huun, Johanna
    Gansmo, Liv B.
    Mannsaker, Bard
    Iversen, Gjertrud Titlestad
    Ovrebo, Jan Inge
    Lonning, Per E.
    Knappskog, Stian
    BMC CELL BIOLOGY, 2017, 18
  • [40] No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer
    Campbell, Ian G.
    Eccles, Diana M.
    Choong, David Y. H.
    CANCER LETTERS, 2006, 240 (02) : 195 - 197
12345